Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

VitaSpring Biomedical Co. Ltd. (VSBC)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
15.500.00 (0.00%)
At close: 3:48PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close15.50
Open15.10
BidN/A x N/A
AskN/A x N/A
Day's Range15.50 - 15.50
52 Week Range8.00 - 15.80
Volume1
Avg. Volume3
Market Cap3.201B
Beta (5Y Monthly)1.59
PE Ratio (TTM)15,500.00
EPS (TTM)0.00
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for VSBC

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • VITASPRING BIOMEDICAL CO LTD
    Analyst Report: Coloplast A/SColoplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy-care systems, disposable containment devices, paste, powder, seals, and wipes. Coloplast also maintains a tertiary presence in the urology and wound-care markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.
    Rating
    Fair Value
    Economic Moat
    yesterdayMorningstar
View more
  • We're sorry we weren't able to find anything about this topic.

Advertisement
Advertisement